nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ALB—hematologic cancer	0.0703	0.512	CbGaD
Phenytoin—ABCB1—hematologic cancer	0.0671	0.488	CbGaD
Phenytoin—CYP2C18—Ifosfamide—hematologic cancer	0.0268	0.0503	CbGbCtD
Phenytoin—ABCC2—Daunorubicin—hematologic cancer	0.0166	0.0312	CbGbCtD
Phenytoin—CYP2B6—Thiotepa—hematologic cancer	0.0149	0.028	CbGbCtD
Phenytoin—SLCO1C1—Methotrexate—hematologic cancer	0.0147	0.0276	CbGbCtD
Phenytoin—CYP2C9—Bexarotene—hematologic cancer	0.00953	0.0179	CbGbCtD
Phenytoin—ABCB1—Lenalidomide—hematologic cancer	0.00925	0.0173	CbGbCtD
Phenytoin—CYP3A7—Ifosfamide—hematologic cancer	0.00891	0.0167	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00891	0.0167	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00851	0.0159	CbGbCtD
Phenytoin—CYP3A7—Imatinib—hematologic cancer	0.00851	0.0159	CbGbCtD
Phenytoin—CYP2B6—Ifosfamide—hematologic cancer	0.00848	0.0159	CbGbCtD
Phenytoin—CYP2C8—Bortezomib—hematologic cancer	0.00838	0.0157	CbGbCtD
Phenytoin—CYP3A5—Daunorubicin—hematologic cancer	0.00833	0.0156	CbGbCtD
Phenytoin—ABCC2—Irinotecan—hematologic cancer	0.00796	0.0149	CbGbCtD
Phenytoin—ALB—Imatinib—hematologic cancer	0.00794	0.0149	CbGbCtD
Phenytoin—CYP2C9—Idarubicin—hematologic cancer	0.0079	0.0148	CbGbCtD
Phenytoin—CYP3A5—Thalidomide—hematologic cancer	0.00759	0.0142	CbGbCtD
Phenytoin—CYP2B6—Nilotinib—hematologic cancer	0.00736	0.0138	CbGbCtD
Phenytoin—CYP3A5—Teniposide—hematologic cancer	0.00724	0.0136	CbGbCtD
Phenytoin—ABCC2—Vinblastine—hematologic cancer	0.00708	0.0133	CbGbCtD
Phenytoin—CYP2C19—Bortezomib—hematologic cancer	0.00703	0.0132	CbGbCtD
Phenytoin—ABCC2—Vincristine—hematologic cancer	0.00696	0.013	CbGbCtD
Phenytoin—CYP3A5—Ifosfamide—hematologic cancer	0.00668	0.0125	CbGbCtD
Phenytoin—ABCC2—Cisplatin—hematologic cancer	0.00649	0.0122	CbGbCtD
Phenytoin—CYP2C8—Ifosfamide—hematologic cancer	0.00642	0.012	CbGbCtD
Phenytoin—CYP3A5—Imatinib—hematologic cancer	0.00638	0.012	CbGbCtD
Phenytoin—ABCC2—Etoposide—hematologic cancer	0.00637	0.0119	CbGbCtD
Phenytoin—CYP2C19—Thalidomide—hematologic cancer	0.00612	0.0115	CbGbCtD
Phenytoin—CYP2C9—Bortezomib—hematologic cancer	0.00584	0.011	CbGbCtD
Phenytoin—CYP2C19—Teniposide—hematologic cancer	0.00584	0.0109	CbGbCtD
Phenytoin—CYP2C8—Nilotinib—hematologic cancer	0.00558	0.0105	CbGbCtD
Phenytoin—CYP3A4—Bexarotene—hematologic cancer	0.00554	0.0104	CbGbCtD
Phenytoin—ABCB1—Daunorubicin—hematologic cancer	0.00542	0.0102	CbGbCtD
Phenytoin—CYP2C19—Ifosfamide—hematologic cancer	0.00539	0.0101	CbGbCtD
Phenytoin—CYP3A7—Irinotecan—hematologic cancer	0.00531	0.00996	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00531	0.00996	CbGbCtD
Phenytoin—ABCB1—Alitretinoin—hematologic cancer	0.00531	0.00996	CbGbCtD
Phenytoin—ABCC2—Dexamethasone—hematologic cancer	0.00524	0.00982	CbGbCtD
Phenytoin—ALB—Prednisone—hematologic cancer	0.00523	0.00981	CbGbCtD
Phenytoin—CYP3A4—Lomustine—hematologic cancer	0.00515	0.00966	CbGbCtD
Phenytoin—CYP3A4—Busulfan—hematologic cancer	0.00515	0.00966	CbGbCtD
Phenytoin—CYP2C19—Imatinib—hematologic cancer	0.00515	0.00965	CbGbCtD
Phenytoin—CYP3A5—Dasatinib—hematologic cancer	0.00513	0.00961	CbGbCtD
Phenytoin—CYP2C9—Thalidomide—hematologic cancer	0.00509	0.00954	CbGbCtD
Phenytoin—CYP2B6—Irinotecan—hematologic cancer	0.00506	0.00949	CbGbCtD
Phenytoin—ALB—Irinotecan—hematologic cancer	0.00496	0.0093	CbGbCtD
Phenytoin—CYP2C9—Teniposide—hematologic cancer	0.00485	0.0091	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00464	0.00871	CbGbCtD
Phenytoin—CYP3A7—Vincristine—hematologic cancer	0.00464	0.00871	CbGbCtD
Phenytoin—CYP3A4—Thiotepa—hematologic cancer	0.00459	0.00861	CbGbCtD
Phenytoin—CYP2C9—Ifosfamide—hematologic cancer	0.00448	0.0084	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—hematologic cancer	0.00435	0.00815	CbGbCtD
Phenytoin—CYP2C9—Imatinib—hematologic cancer	0.00428	0.00802	CbGbCtD
Phenytoin—ABCC2—Methotrexate—hematologic cancer	0.00421	0.0079	CbGbCtD
Phenytoin—ABCB1—Imatinib—hematologic cancer	0.00415	0.00779	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—hematologic cancer	0.00413	0.00773	CbGbCtD
Phenytoin—CYP3A5—Irinotecan—hematologic cancer	0.00399	0.00747	CbGbCtD
Phenytoin—CYP2C9—Nilotinib—hematologic cancer	0.00389	0.00729	CbGbCtD
Phenytoin—ABCB1—Nilotinib—hematologic cancer	0.00377	0.00708	CbGbCtD
Phenytoin—ABCB1—Vinorelbine—hematologic cancer	0.00374	0.00702	CbGbCtD
Phenytoin—CYP3A4—Methoxsalen—hematologic cancer	0.00357	0.00669	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.0035	0.00656	CbGbCtD
Phenytoin—CYP3A7—Dexamethasone—hematologic cancer	0.0035	0.00656	CbGbCtD
Phenytoin—CYP3A5—Vincristine—hematologic cancer	0.00348	0.00653	CbGbCtD
Phenytoin—CYP3A4—Bortezomib—hematologic cancer	0.0034	0.00637	CbGbCtD
Phenytoin—CYP2C19—Prednisone—hematologic cancer	0.00339	0.00636	CbGbCtD
Phenytoin—ABCB1—Dasatinib—hematologic cancer	0.00334	0.00625	CbGbCtD
Phenytoin—CYP2B6—Dexamethasone—hematologic cancer	0.00333	0.00625	CbGbCtD
Phenytoin—ABCB1—Mitoxantrone—hematologic cancer	0.0033	0.00618	CbGbCtD
Phenytoin—CYP3A4—Daunorubicin—hematologic cancer	0.00325	0.00609	CbGbCtD
Phenytoin—CYP3A5—Etoposide—hematologic cancer	0.00319	0.00599	CbGbCtD
Phenytoin—CYP2C8—Etoposide—hematologic cancer	0.00307	0.00576	CbGbCtD
Phenytoin—ABCB1—Betamethasone—hematologic cancer	0.00294	0.00551	CbGbCtD
Phenytoin—ABCB1—Gemcitabine—hematologic cancer	0.00291	0.00546	CbGbCtD
Phenytoin—ABCB1—Prednisolone—hematologic cancer	0.0029	0.00543	CbGbCtD
Phenytoin—CYP3A4—Cytarabine—hematologic cancer	0.00287	0.00537	CbGbCtD
Phenytoin—CYP3A4—Teniposide—hematologic cancer	0.00282	0.00529	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—hematologic cancer	0.00276	0.00518	CbGbCtD
Phenytoin—ABCB1—Prednisone—hematologic cancer	0.00274	0.00513	CbGbCtD
Phenytoin—CYP3A5—Dexamethasone—hematologic cancer	0.00263	0.00492	CbGbCtD
Phenytoin—ALB—Methotrexate—hematologic cancer	0.00262	0.00492	CbGbCtD
Phenytoin—CYP3A4—Ifosfamide—hematologic cancer	0.00261	0.00488	CbGbCtD
Phenytoin—ABCB1—Irinotecan—hematologic cancer	0.00259	0.00486	CbGbCtD
Phenytoin—CYP2C8—Dexamethasone—hematologic cancer	0.00252	0.00473	CbGbCtD
Phenytoin—CYP3A4—Imatinib—hematologic cancer	0.00249	0.00467	CbGbCtD
Phenytoin—CYP3A4—Ruxolitinib—hematologic cancer	0.00234	0.00439	CbGbCtD
Phenytoin—ABCB1—Vinblastine—hematologic cancer	0.00231	0.00432	CbGbCtD
Phenytoin—ABCB1—Vincristine—hematologic cancer	0.00227	0.00425	CbGbCtD
Phenytoin—CYP3A4—Nilotinib—hematologic cancer	0.00226	0.00424	CbGbCtD
Phenytoin—CYP3A4—Vinorelbine—hematologic cancer	0.00224	0.0042	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—hematologic cancer	0.00218	0.00409	CbGbCtD
Phenytoin—CYP2C19—Dexamethasone—hematologic cancer	0.00212	0.00397	CbGbCtD
Phenytoin—ABCB1—Cisplatin—hematologic cancer	0.00211	0.00396	CbGbCtD
Phenytoin—ABCB1—Etoposide—hematologic cancer	0.00208	0.0039	CbGbCtD
Phenytoin—CYP3A4—Triamcinolone—hematologic cancer	0.00205	0.00385	CbGbCtD
Phenytoin—CYP3A4—Dasatinib—hematologic cancer	0.002	0.00375	CbGbCtD
Phenytoin—CYP3A4—Mitoxantrone—hematologic cancer	0.00197	0.0037	CbGbCtD
Phenytoin—CYP11B1—hematopoietic system—hematologic cancer	0.00195	0.0861	CbGeAlD
Phenytoin—CYP2C9—Dexamethasone—hematologic cancer	0.00176	0.0033	CbGbCtD
Phenytoin—CYP3A4—Betamethasone—hematologic cancer	0.00176	0.0033	CbGbCtD
Phenytoin—CYP3A4—Prednisolone—hematologic cancer	0.00174	0.00325	CbGbCtD
Phenytoin—ABCB1—Dexamethasone—hematologic cancer	0.00171	0.0032	CbGbCtD
Phenytoin—CYP3A4—Prednisone—hematologic cancer	0.00164	0.00307	CbGbCtD
Phenytoin—CYP3A4—Irinotecan—hematologic cancer	0.00155	0.00291	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—hematologic cancer	0.00142	0.00266	CbGbCtD
Phenytoin—CYP3A4—Vinblastine—hematologic cancer	0.00138	0.00259	CbGbCtD
Phenytoin—ABCB1—Methotrexate—hematologic cancer	0.00137	0.00257	CbGbCtD
Phenytoin—CYP3A4—Vincristine—hematologic cancer	0.00136	0.00255	CbGbCtD
Phenytoin—CYP11B1—blood—hematologic cancer	0.00129	0.0571	CbGeAlD
Phenytoin—CYP3A4—Etoposide—hematologic cancer	0.00125	0.00233	CbGbCtD
Phenytoin—SCN2A—hematopoietic system—hematologic cancer	0.00105	0.0462	CbGeAlD
Phenytoin—CYP3A4—Dexamethasone—hematologic cancer	0.00102	0.00192	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—hematologic cancer	0.000849	0.00159	CbGbCtD
Phenytoin—SCN8A—testis—hematologic cancer	0.000827	0.0365	CbGeAlD
Phenytoin—SCN9A—lung—hematologic cancer	0.00077	0.034	CbGeAlD
Phenytoin—SCN9A—testis—hematologic cancer	0.000727	0.0321	CbGeAlD
Phenytoin—SLCO1C1—testis—hematologic cancer	0.000705	0.0311	CbGeAlD
Phenytoin—SCN2A—blood—hematologic cancer	0.000694	0.0306	CbGeAlD
Phenytoin—SCN1A—lung—hematologic cancer	0.000662	0.0292	CbGeAlD
Phenytoin—SCN4A—testis—hematologic cancer	0.000648	0.0286	CbGeAlD
Phenytoin—SCN3A—blood—hematologic cancer	0.00061	0.0269	CbGeAlD
Phenytoin—SCN5A—blood—hematologic cancer	0.000608	0.0268	CbGeAlD
Phenytoin—CYP2C19—hematopoietic system—hematologic cancer	0.000591	0.0261	CbGeAlD
Phenytoin—SCN3A—bone marrow—hematologic cancer	0.00059	0.026	CbGeAlD
Phenytoin—SCN3A—lung—hematologic cancer	0.000534	0.0236	CbGeAlD
Phenytoin—SCN9A—lymph node—hematologic cancer	0.000527	0.0232	CbGeAlD
Phenytoin—CYP2C8—hematopoietic system—hematologic cancer	0.000516	0.0228	CbGeAlD
Phenytoin—SLCO1C1—lymph node—hematologic cancer	0.000511	0.0226	CbGeAlD
Phenytoin—SCN3A—testis—hematologic cancer	0.000504	0.0222	CbGeAlD
Phenytoin—CYP3A5—hematopoietic system—hematologic cancer	0.000466	0.0206	CbGeAlD
Phenytoin—CYP2B6—hematopoietic system—hematologic cancer	0.000463	0.0204	CbGeAlD
Phenytoin—CYP2C9—hematopoietic system—hematologic cancer	0.000458	0.0202	CbGeAlD
Phenytoin—ABCC2—blood—hematologic cancer	0.000456	0.0201	CbGeAlD
Phenytoin—ALB—testis—hematologic cancer	0.000402	0.0178	CbGeAlD
Phenytoin—CYP2C19—blood—hematologic cancer	0.000392	0.0173	CbGeAlD
Phenytoin—ABCC2—testis—hematologic cancer	0.000377	0.0166	CbGeAlD
Phenytoin—SCN3A—lymph node—hematologic cancer	0.000365	0.0161	CbGeAlD
Phenytoin—CYP2B6—gonad—hematologic cancer	0.000352	0.0155	CbGeAlD
Phenytoin—CYP3A4—hematopoietic system—hematologic cancer	0.00035	0.0154	CbGeAlD
Phenytoin—CYP2C8—blood—hematologic cancer	0.000342	0.0151	CbGeAlD
Phenytoin—CYP3A5—blood—hematologic cancer	0.000309	0.0136	CbGeAlD
Phenytoin—CYP2B6—blood—hematologic cancer	0.000307	0.0135	CbGeAlD
Phenytoin—CYP2C9—blood—hematologic cancer	0.000304	0.0134	CbGeAlD
Phenytoin—ALB—lymph node—hematologic cancer	0.000292	0.0129	CbGeAlD
Phenytoin—CYP2C8—testis—hematologic cancer	0.000283	0.0125	CbGeAlD
Phenytoin—ABCC2—lymph node—hematologic cancer	0.000273	0.0121	CbGeAlD
Phenytoin—CYP3A5—lung—hematologic cancer	0.000271	0.0119	CbGeAlD
Phenytoin—CYP2B6—lung—hematologic cancer	0.000269	0.0119	CbGeAlD
Phenytoin—CYP2B6—testis—hematologic cancer	0.000254	0.0112	CbGeAlD
Phenytoin—ABCB1—hematopoietic system—hematologic cancer	0.000247	0.0109	CbGeAlD
Phenytoin—CYP3A4—blood—hematologic cancer	0.000232	0.0102	CbGeAlD
Phenytoin—ABCB1—gonad—hematologic cancer	0.000188	0.0083	CbGeAlD
Phenytoin—ABCB1—blood—hematologic cancer	0.000164	0.00723	CbGeAlD
Phenytoin—ABCB1—bone marrow—hematologic cancer	0.000159	0.007	CbGeAlD
Phenytoin—Phenobarbital—ABCC3—hematologic cancer	0.00015	0.319	CrCbGaD
Phenytoin—ABCB1—lung—hematologic cancer	0.000144	0.00634	CbGeAlD
Phenytoin—ABCB1—testis—hematologic cancer	0.000136	0.00598	CbGeAlD
Phenytoin—ABCB1—lymph node—hematologic cancer	9.83e-05	0.00434	CbGeAlD
Phenytoin—Diphenhydramine—SLC22A1—hematologic cancer	8.54e-05	0.181	CrCbGaD
Phenytoin—Fosphenytoin—ALB—hematologic cancer	7.52e-05	0.16	CrCbGaD
Phenytoin—Phenprocoumon—ALB—hematologic cancer	5.15e-05	0.109	CrCbGaD
Phenytoin—Warfarin—ALB—hematologic cancer	4.57e-05	0.097	CrCbGaD
Phenytoin—Carbamazepine—ABCB1—hematologic cancer	3.26e-05	0.0692	CrCbGaD
Phenytoin—Phenobarbital—ABCB1—hematologic cancer	3.04e-05	0.0645	CrCbGaD
Phenytoin—Dysgeusia—Methotrexate—hematologic cancer	1.48e-05	6.32e-05	CcSEcCtD
Phenytoin—Asthenia—Etoposide—hematologic cancer	1.48e-05	6.31e-05	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—hematologic cancer	1.48e-05	6.31e-05	CcSEcCtD
Phenytoin—Body temperature increased—Triamcinolone—hematologic cancer	1.48e-05	6.3e-05	CcSEcCtD
Phenytoin—Anaphylactic shock—Prednisone—hematologic cancer	1.47e-05	6.3e-05	CcSEcCtD
Phenytoin—Decreased appetite—Betamethasone—hematologic cancer	1.47e-05	6.29e-05	CcSEcCtD
Phenytoin—Decreased appetite—Dexamethasone—hematologic cancer	1.47e-05	6.29e-05	CcSEcCtD
Phenytoin—Nausea—Mitoxantrone—hematologic cancer	1.47e-05	6.28e-05	CcSEcCtD
Phenytoin—Nausea—Irinotecan—hematologic cancer	1.47e-05	6.28e-05	CcSEcCtD
Phenytoin—Immune system disorder—Epirubicin—hematologic cancer	1.47e-05	6.26e-05	CcSEcCtD
Phenytoin—Infection—Prednisone—hematologic cancer	1.47e-05	6.26e-05	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.46e-05	6.25e-05	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.46e-05	6.25e-05	CcSEcCtD
Phenytoin—Back pain—Methotrexate—hematologic cancer	1.46e-05	6.24e-05	CcSEcCtD
Phenytoin—Fatigue—Dexamethasone—hematologic cancer	1.46e-05	6.24e-05	CcSEcCtD
Phenytoin—Fatigue—Betamethasone—hematologic cancer	1.46e-05	6.24e-05	CcSEcCtD
Phenytoin—Chills—Epirubicin—hematologic cancer	1.46e-05	6.22e-05	CcSEcCtD
Phenytoin—Pruritus—Etoposide—hematologic cancer	1.46e-05	6.22e-05	CcSEcCtD
Phenytoin—Shock—Prednisone—hematologic cancer	1.45e-05	6.2e-05	CcSEcCtD
Phenytoin—Nervous system disorder—Prednisone—hematologic cancer	1.45e-05	6.18e-05	CcSEcCtD
Phenytoin—Tachycardia—Prednisone—hematologic cancer	1.44e-05	6.15e-05	CcSEcCtD
Phenytoin—Nausea—Gemcitabine—hematologic cancer	1.43e-05	6.11e-05	CcSEcCtD
Phenytoin—Vomiting—Cisplatin—hematologic cancer	1.43e-05	6.1e-05	CcSEcCtD
Phenytoin—Hyperhidrosis—Prednisone—hematologic cancer	1.43e-05	6.09e-05	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—hematologic cancer	1.42e-05	6.07e-05	CcSEcCtD
Phenytoin—Rash—Cisplatin—hematologic cancer	1.42e-05	6.05e-05	CcSEcCtD
Phenytoin—Dermatitis—Cisplatin—hematologic cancer	1.41e-05	6.04e-05	CcSEcCtD
Phenytoin—Diarrhoea—Etoposide—hematologic cancer	1.41e-05	6.01e-05	CcSEcCtD
Phenytoin—Anorexia—Prednisone—hematologic cancer	1.41e-05	6.01e-05	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—hematologic cancer	1.4e-05	5.99e-05	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—hematologic cancer	1.4e-05	5.98e-05	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—hematologic cancer	1.4e-05	5.96e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Dexamethasone—hematologic cancer	1.4e-05	5.96e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Betamethasone—hematologic cancer	1.4e-05	5.96e-05	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—hematologic cancer	1.39e-05	5.95e-05	CcSEcCtD
Phenytoin—Tension—Epirubicin—hematologic cancer	1.39e-05	5.92e-05	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—hematologic cancer	1.38e-05	5.91e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Triamcinolone—hematologic cancer	1.38e-05	5.87e-05	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—hematologic cancer	1.37e-05	5.86e-05	CcSEcCtD
Phenytoin—Back pain—Epirubicin—hematologic cancer	1.37e-05	5.84e-05	CcSEcCtD
Phenytoin—Malaise—Methotrexate—hematologic cancer	1.36e-05	5.82e-05	CcSEcCtD
Phenytoin—Dizziness—Etoposide—hematologic cancer	1.36e-05	5.81e-05	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—hematologic cancer	1.36e-05	5.8e-05	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—hematologic cancer	1.36e-05	5.8e-05	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—hematologic cancer	1.36e-05	5.8e-05	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—hematologic cancer	1.35e-05	5.78e-05	CcSEcCtD
Phenytoin—Chills—Doxorubicin—hematologic cancer	1.35e-05	5.76e-05	CcSEcCtD
Phenytoin—Urticaria—Dexamethasone—hematologic cancer	1.35e-05	5.75e-05	CcSEcCtD
Phenytoin—Urticaria—Betamethasone—hematologic cancer	1.35e-05	5.75e-05	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.34e-05	5.74e-05	CcSEcCtD
Phenytoin—Dizziness—Prednisolone—hematologic cancer	1.34e-05	5.73e-05	CcSEcCtD
Phenytoin—Asthenia—Triamcinolone—hematologic cancer	1.34e-05	5.72e-05	CcSEcCtD
Phenytoin—Body temperature increased—Betamethasone—hematologic cancer	1.34e-05	5.72e-05	CcSEcCtD
Phenytoin—Body temperature increased—Dexamethasone—hematologic cancer	1.34e-05	5.72e-05	CcSEcCtD
Phenytoin—Nausea—Cisplatin—hematologic cancer	1.33e-05	5.7e-05	CcSEcCtD
Phenytoin—Insomnia—Prednisone—hematologic cancer	1.33e-05	5.7e-05	CcSEcCtD
Phenytoin—Paraesthesia—Prednisone—hematologic cancer	1.32e-05	5.66e-05	CcSEcCtD
Phenytoin—Pruritus—Triamcinolone—hematologic cancer	1.32e-05	5.64e-05	CcSEcCtD
Phenytoin—Cough—Methotrexate—hematologic cancer	1.32e-05	5.63e-05	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—hematologic cancer	1.31e-05	5.6e-05	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—hematologic cancer	1.31e-05	5.59e-05	CcSEcCtD
Phenytoin—Vomiting—Etoposide—hematologic cancer	1.31e-05	5.59e-05	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—hematologic cancer	1.31e-05	5.58e-05	CcSEcCtD
Phenytoin—Agitation—Epirubicin—hematologic cancer	1.3e-05	5.55e-05	CcSEcCtD
Phenytoin—Dyspepsia—Prednisone—hematologic cancer	1.3e-05	5.55e-05	CcSEcCtD
Phenytoin—Rash—Etoposide—hematologic cancer	1.3e-05	5.54e-05	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—hematologic cancer	1.3e-05	5.54e-05	CcSEcCtD
Phenytoin—Headache—Etoposide—hematologic cancer	1.29e-05	5.51e-05	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—hematologic cancer	1.29e-05	5.5e-05	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—hematologic cancer	1.29e-05	5.49e-05	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—hematologic cancer	1.29e-05	5.49e-05	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—hematologic cancer	1.29e-05	5.49e-05	CcSEcCtD
Phenytoin—Tension—Doxorubicin—hematologic cancer	1.28e-05	5.48e-05	CcSEcCtD
Phenytoin—Decreased appetite—Prednisone—hematologic cancer	1.28e-05	5.48e-05	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—hematologic cancer	1.28e-05	5.47e-05	CcSEcCtD
Phenytoin—Rash—Prednisolone—hematologic cancer	1.28e-05	5.47e-05	CcSEcCtD
Phenytoin—Dermatitis—Prednisolone—hematologic cancer	1.28e-05	5.46e-05	CcSEcCtD
Phenytoin—Malaise—Epirubicin—hematologic cancer	1.27e-05	5.44e-05	CcSEcCtD
Phenytoin—Fatigue—Prednisone—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Phenytoin—Headache—Prednisolone—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—hematologic cancer	1.27e-05	5.42e-05	CcSEcCtD
Phenytoin—Syncope—Epirubicin—hematologic cancer	1.27e-05	5.41e-05	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—hematologic cancer	1.27e-05	5.4e-05	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—hematologic cancer	1.26e-05	5.4e-05	CcSEcCtD
Phenytoin—Constipation—Prednisone—hematologic cancer	1.26e-05	5.39e-05	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—hematologic cancer	1.26e-05	5.37e-05	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—hematologic cancer	1.25e-05	5.34e-05	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—hematologic cancer	1.24e-05	5.31e-05	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—hematologic cancer	1.24e-05	5.31e-05	CcSEcCtD
Phenytoin—Dizziness—Triamcinolone—hematologic cancer	1.23e-05	5.27e-05	CcSEcCtD
Phenytoin—Cough—Epirubicin—hematologic cancer	1.23e-05	5.27e-05	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—hematologic cancer	1.23e-05	5.27e-05	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—hematologic cancer	1.22e-05	5.23e-05	CcSEcCtD
Phenytoin—Infection—Methotrexate—hematologic cancer	1.22e-05	5.23e-05	CcSEcCtD
Phenytoin—Nausea—Etoposide—hematologic cancer	1.22e-05	5.22e-05	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—hematologic cancer	1.22e-05	5.21e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Prednisone—hematologic cancer	1.22e-05	5.19e-05	CcSEcCtD
Phenytoin—Asthenia—Betamethasone—hematologic cancer	1.22e-05	5.19e-05	CcSEcCtD
Phenytoin—Asthenia—Dexamethasone—hematologic cancer	1.22e-05	5.19e-05	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.21e-05	5.18e-05	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—hematologic cancer	1.21e-05	5.16e-05	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—hematologic cancer	1.21e-05	5.16e-05	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—hematologic cancer	1.21e-05	5.16e-05	CcSEcCtD
Phenytoin—Nausea—Prednisolone—hematologic cancer	1.21e-05	5.15e-05	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—hematologic cancer	1.2e-05	5.13e-05	CcSEcCtD
Phenytoin—Pruritus—Betamethasone—hematologic cancer	1.2e-05	5.12e-05	CcSEcCtD
Phenytoin—Pruritus—Dexamethasone—hematologic cancer	1.2e-05	5.12e-05	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—hematologic cancer	1.19e-05	5.09e-05	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—hematologic cancer	1.19e-05	5.08e-05	CcSEcCtD
Phenytoin—Vomiting—Triamcinolone—hematologic cancer	1.19e-05	5.07e-05	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—hematologic cancer	1.18e-05	5.04e-05	CcSEcCtD
Phenytoin—Rash—Triamcinolone—hematologic cancer	1.18e-05	5.03e-05	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—hematologic cancer	1.18e-05	5.03e-05	CcSEcCtD
Phenytoin—Dermatitis—Triamcinolone—hematologic cancer	1.18e-05	5.02e-05	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—hematologic cancer	1.17e-05	5.02e-05	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—hematologic cancer	1.17e-05	5.02e-05	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—hematologic cancer	1.17e-05	5.01e-05	CcSEcCtD
Phenytoin—Urticaria—Prednisone—hematologic cancer	1.17e-05	5.01e-05	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—hematologic cancer	1.17e-05	5e-05	CcSEcCtD
Phenytoin—Headache—Triamcinolone—hematologic cancer	1.17e-05	5e-05	CcSEcCtD
Phenytoin—Body temperature increased—Prednisone—hematologic cancer	1.17e-05	4.98e-05	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—hematologic cancer	1.16e-05	4.97e-05	CcSEcCtD
Phenytoin—Diarrhoea—Dexamethasone—hematologic cancer	1.16e-05	4.95e-05	CcSEcCtD
Phenytoin—Diarrhoea—Betamethasone—hematologic cancer	1.16e-05	4.95e-05	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—hematologic cancer	1.16e-05	4.94e-05	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—hematologic cancer	1.15e-05	4.93e-05	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—hematologic cancer	1.15e-05	4.92e-05	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—hematologic cancer	1.15e-05	4.91e-05	CcSEcCtD
Phenytoin—Infection—Epirubicin—hematologic cancer	1.15e-05	4.9e-05	CcSEcCtD
Phenytoin—Cough—Doxorubicin—hematologic cancer	1.14e-05	4.87e-05	CcSEcCtD
Phenytoin—Shock—Epirubicin—hematologic cancer	1.13e-05	4.85e-05	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—hematologic cancer	1.13e-05	4.84e-05	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—hematologic cancer	1.13e-05	4.83e-05	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—hematologic cancer	1.13e-05	4.82e-05	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—hematologic cancer	1.13e-05	4.82e-05	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—hematologic cancer	1.13e-05	4.81e-05	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.12e-05	4.8e-05	CcSEcCtD
Phenytoin—Dizziness—Betamethasone—hematologic cancer	1.12e-05	4.78e-05	CcSEcCtD
Phenytoin—Dizziness—Dexamethasone—hematologic cancer	1.12e-05	4.78e-05	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—hematologic cancer	1.12e-05	4.76e-05	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Phenytoin—Nausea—Triamcinolone—hematologic cancer	1.11e-05	4.74e-05	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—hematologic cancer	1.11e-05	4.73e-05	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—hematologic cancer	1.1e-05	4.7e-05	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—hematologic cancer	1.1e-05	4.7e-05	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—hematologic cancer	1.1e-05	4.69e-05	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—hematologic cancer	1.1e-05	4.68e-05	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—hematologic cancer	1.09e-05	4.65e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Prednisone—hematologic cancer	1.09e-05	4.64e-05	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—hematologic cancer	1.08e-05	4.64e-05	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—hematologic cancer	1.08e-05	4.6e-05	CcSEcCtD
Phenytoin—Vomiting—Betamethasone—hematologic cancer	1.08e-05	4.6e-05	CcSEcCtD
Phenytoin—Vomiting—Dexamethasone—hematologic cancer	1.08e-05	4.6e-05	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—hematologic cancer	1.08e-05	4.6e-05	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—hematologic cancer	1.07e-05	4.58e-05	CcSEcCtD
Phenytoin—Rash—Betamethasone—hematologic cancer	1.07e-05	4.56e-05	CcSEcCtD
Phenytoin—Rash—Dexamethasone—hematologic cancer	1.07e-05	4.56e-05	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.07e-05	4.56e-05	CcSEcCtD
Phenytoin—Dermatitis—Betamethasone—hematologic cancer	1.07e-05	4.56e-05	CcSEcCtD
Phenytoin—Dermatitis—Dexamethasone—hematologic cancer	1.07e-05	4.56e-05	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.06e-05	4.55e-05	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—hematologic cancer	1.06e-05	4.54e-05	CcSEcCtD
Phenytoin—Headache—Dexamethasone—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Phenytoin—Headache—Betamethasone—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Phenytoin—Infection—Doxorubicin—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Phenytoin—Asthenia—Prednisone—hematologic cancer	1.06e-05	4.52e-05	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.05e-05	4.49e-05	CcSEcCtD
Phenytoin—Shock—Doxorubicin—hematologic cancer	1.05e-05	4.49e-05	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—hematologic cancer	1.05e-05	4.47e-05	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Phenytoin—Pruritus—Prednisone—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—hematologic cancer	1.04e-05	4.45e-05	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—hematologic cancer	1.04e-05	4.42e-05	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.03e-05	4.41e-05	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—hematologic cancer	1.03e-05	4.39e-05	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—hematologic cancer	1.03e-05	4.38e-05	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—hematologic cancer	1.02e-05	4.35e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—hematologic cancer	1.02e-05	4.34e-05	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—hematologic cancer	1.02e-05	4.34e-05	CcSEcCtD
Phenytoin—Diarrhoea—Prednisone—hematologic cancer	1.01e-05	4.31e-05	CcSEcCtD
Phenytoin—Nausea—Dexamethasone—hematologic cancer	1.01e-05	4.3e-05	CcSEcCtD
Phenytoin—Nausea—Betamethasone—hematologic cancer	1.01e-05	4.3e-05	CcSEcCtD
Phenytoin—Decreased appetite—Epirubicin—hematologic cancer	1e-05	4.28e-05	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—hematologic cancer	9.97e-06	4.26e-05	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.96e-06	4.25e-05	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—hematologic cancer	9.94e-06	4.25e-05	CcSEcCtD
Phenytoin—Constipation—Epirubicin—hematologic cancer	9.86e-06	4.21e-05	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—hematologic cancer	9.79e-06	4.18e-05	CcSEcCtD
Phenytoin—Dizziness—Prednisone—hematologic cancer	9.75e-06	4.17e-05	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—hematologic cancer	9.74e-06	4.16e-05	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.72e-06	4.15e-05	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—hematologic cancer	9.65e-06	4.12e-05	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—hematologic cancer	9.58e-06	4.09e-05	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—hematologic cancer	9.52e-06	4.06e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—hematologic cancer	9.51e-06	4.06e-05	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—hematologic cancer	9.49e-06	4.05e-05	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—hematologic cancer	9.39e-06	4.01e-05	CcSEcCtD
Phenytoin—Vomiting—Prednisone—hematologic cancer	9.38e-06	4.01e-05	CcSEcCtD
Phenytoin—Rash—Prednisone—hematologic cancer	9.3e-06	3.97e-05	CcSEcCtD
Phenytoin—Dermatitis—Prednisone—hematologic cancer	9.29e-06	3.97e-05	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—hematologic cancer	9.28e-06	3.96e-05	CcSEcCtD
Phenytoin—Headache—Prednisone—hematologic cancer	9.24e-06	3.95e-05	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.21e-06	3.94e-05	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—hematologic cancer	9.2e-06	3.93e-05	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—hematologic cancer	9.16e-06	3.91e-05	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—hematologic cancer	9.13e-06	3.9e-05	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—hematologic cancer	9.12e-06	3.9e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—hematologic cancer	9.08e-06	3.88e-05	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—hematologic cancer	8.84e-06	3.78e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—hematologic cancer	8.79e-06	3.76e-05	CcSEcCtD
Phenytoin—Nausea—Prednisone—hematologic cancer	8.76e-06	3.74e-05	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—hematologic cancer	8.72e-06	3.73e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Epirubicin—hematologic cancer	8.5e-06	3.63e-05	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—hematologic cancer	8.48e-06	3.62e-05	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—hematologic cancer	8.44e-06	3.6e-05	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—hematologic cancer	8.43e-06	3.6e-05	CcSEcCtD
Phenytoin—Asthenia—Epirubicin—hematologic cancer	8.28e-06	3.54e-05	CcSEcCtD
Phenytoin—Pruritus—Epirubicin—hematologic cancer	8.16e-06	3.49e-05	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—hematologic cancer	8.15e-06	3.48e-05	CcSEcCtD
Phenytoin—Diarrhoea—Epirubicin—hematologic cancer	7.89e-06	3.37e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—hematologic cancer	7.86e-06	3.36e-05	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—hematologic cancer	7.84e-06	3.35e-05	CcSEcCtD
Phenytoin—Rash—Methotrexate—hematologic cancer	7.77e-06	3.32e-05	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—hematologic cancer	7.76e-06	3.32e-05	CcSEcCtD
Phenytoin—Headache—Methotrexate—hematologic cancer	7.72e-06	3.3e-05	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—hematologic cancer	7.66e-06	3.27e-05	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—hematologic cancer	7.63e-06	3.26e-05	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—hematologic cancer	7.55e-06	3.23e-05	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—hematologic cancer	7.33e-06	3.13e-05	CcSEcCtD
Phenytoin—Nausea—Methotrexate—hematologic cancer	7.32e-06	3.13e-05	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—hematologic cancer	7.3e-06	3.12e-05	CcSEcCtD
Phenytoin—Rash—Epirubicin—hematologic cancer	7.27e-06	3.11e-05	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—hematologic cancer	7.27e-06	3.1e-05	CcSEcCtD
Phenytoin—Headache—Epirubicin—hematologic cancer	7.23e-06	3.09e-05	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—hematologic cancer	7.06e-06	3.02e-05	CcSEcCtD
Phenytoin—Nausea—Epirubicin—hematologic cancer	6.85e-06	2.93e-05	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—hematologic cancer	6.79e-06	2.9e-05	CcSEcCtD
Phenytoin—Rash—Doxorubicin—hematologic cancer	6.73e-06	2.87e-05	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—hematologic cancer	6.72e-06	2.87e-05	CcSEcCtD
Phenytoin—Headache—Doxorubicin—hematologic cancer	6.69e-06	2.86e-05	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—hematologic cancer	6.34e-06	2.71e-05	CcSEcCtD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.65e-06	5.08e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO2—hematologic cancer	3.65e-06	5.07e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—MTR—hematologic cancer	3.63e-06	5.05e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ABCG2—hematologic cancer	3.63e-06	5.05e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYCS—hematologic cancer	3.6e-06	5e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NUP98—hematologic cancer	3.59e-06	4.99e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.57e-06	4.97e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.56e-06	4.95e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—hematologic cancer	3.56e-06	4.95e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.54e-06	4.92e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CB—hematologic cancer	3.52e-06	4.9e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.49e-06	4.86e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.48e-06	4.85e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.48e-06	4.85e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.48e-06	4.84e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.47e-06	4.83e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—FHL2—hematologic cancer	3.47e-06	4.83e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NUP214—hematologic cancer	3.46e-06	4.81e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SDC1—hematologic cancer	3.46e-06	4.81e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTT1—hematologic cancer	3.45e-06	4.8e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CB—hematologic cancer	3.45e-06	4.8e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.42e-06	4.76e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AGRN—hematologic cancer	3.4e-06	4.73e-05	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.4e-06	4.73e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—MTR—hematologic cancer	3.39e-06	4.71e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.39e-06	4.71e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SDC1—hematologic cancer	3.37e-06	4.69e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.35e-06	4.66e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO2—hematologic cancer	3.32e-06	4.62e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.3e-06	4.59e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CD44—hematologic cancer	3.29e-06	4.58e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NQO1—hematologic cancer	3.29e-06	4.58e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NQO1—hematologic cancer	3.27e-06	4.55e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CD44—hematologic cancer	3.27e-06	4.55e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.26e-06	4.53e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.24e-06	4.51e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL2—hematologic cancer	3.23e-06	4.5e-05	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.23e-06	4.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—IDH2—hematologic cancer	3.22e-06	4.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HMMR—hematologic cancer	3.22e-06	4.49e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.22e-06	4.48e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.22e-06	4.48e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.21e-06	4.46e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.17e-06	4.42e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.17e-06	4.41e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SDC1—hematologic cancer	3.15e-06	4.38e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.12e-06	4.34e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYCS—hematologic cancer	3.11e-06	4.33e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYCS—hematologic cancer	3.1e-06	4.31e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.1e-06	4.31e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	4.28e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.07e-06	4.27e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.03e-06	4.22e-05	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.02e-06	4.21e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.01e-06	4.19e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—hematologic cancer	3e-06	4.17e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CG—hematologic cancer	2.99e-06	4.16e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTM1—hematologic cancer	2.98e-06	4.15e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NCOR1—hematologic cancer	2.98e-06	4.15e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTEN—hematologic cancer	2.98e-06	4.15e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.97e-06	4.13e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ACP5—hematologic cancer	2.95e-06	4.1e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA9—hematologic cancer	2.95e-06	4.1e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NQO1—hematologic cancer	2.94e-06	4.09e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CD44—hematologic cancer	2.94e-06	4.09e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.91e-06	4.05e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.91e-06	4.05e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.91e-06	4.05e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—EP300—hematologic cancer	2.9e-06	4.04e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.88e-06	4e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CD44—hematologic cancer	2.87e-06	3.99e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NQO1—hematologic cancer	2.87e-06	3.99e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—EP300—hematologic cancer	2.84e-06	3.95e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.84e-06	3.95e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CA—hematologic cancer	2.84e-06	3.95e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SRC—hematologic cancer	2.82e-06	3.92e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.79e-06	3.87e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYCS—hematologic cancer	2.78e-06	3.87e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CREBBP—hematologic cancer	2.77e-06	3.86e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—IDH1—hematologic cancer	2.77e-06	3.86e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.77e-06	3.85e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.76e-06	3.84e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—hematologic cancer	2.75e-06	3.82e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.75e-06	3.82e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TXN—hematologic cancer	2.74e-06	3.81e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.74e-06	3.81e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.74e-06	3.81e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTP1—hematologic cancer	2.73e-06	3.8e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—hematologic cancer	2.71e-06	3.78e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYCS—hematologic cancer	2.71e-06	3.78e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.7e-06	3.75e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.68e-06	3.73e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NQO1—hematologic cancer	2.68e-06	3.73e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CD44—hematologic cancer	2.68e-06	3.73e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.66e-06	3.7e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.64e-06	3.67e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.63e-06	3.66e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.63e-06	3.66e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.62e-06	3.65e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—MAPK3—hematologic cancer	2.6e-06	3.62e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.6e-06	3.62e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ALB—hematologic cancer	2.6e-06	3.61e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—hematologic cancer	2.58e-06	3.59e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.58e-06	3.59e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.57e-06	3.58e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYCS—hematologic cancer	2.54e-06	3.53e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.52e-06	3.51e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.52e-06	3.51e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TGFB1—hematologic cancer	2.52e-06	3.51e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.52e-06	3.5e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTM1—hematologic cancer	2.51e-06	3.49e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NCOR1—hematologic cancer	2.51e-06	3.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.51e-06	3.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.51e-06	3.49e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.49e-06	3.46e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.48e-06	3.46e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.45e-06	3.41e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.44e-06	3.4e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTP1—hematologic cancer	2.39e-06	3.33e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.37e-06	3.3e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.37e-06	3.29e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—hematologic cancer	2.34e-06	3.25e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AKT1—hematologic cancer	2.32e-06	3.23e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.32e-06	3.23e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.3e-06	3.2e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.3e-06	3.2e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.29e-06	3.19e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.28e-06	3.17e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.27e-06	3.15e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.25e-06	3.13e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.25e-06	3.13e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—MTR—hematologic cancer	2.24e-06	3.11e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.24e-06	3.11e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.23e-06	3.11e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.23e-06	3.1e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—MTHFR—hematologic cancer	2.22e-06	3.08e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.21e-06	3.08e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTM1—hematologic cancer	2.2e-06	3.06e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NCOR1—hematologic cancer	2.2e-06	3.06e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—hematologic cancer	2.19e-06	3.05e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.16e-06	3.01e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.16e-06	3.01e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—hematologic cancer	2.15e-06	2.99e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.13e-06	2.96e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.12e-06	2.94e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—hematologic cancer	2.1e-06	2.92e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.08e-06	2.89e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—hematologic cancer	2.08e-06	2.89e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.05e-06	2.86e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.05e-06	2.86e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.05e-06	2.85e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.01e-06	2.79e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.99e-06	2.77e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—hematologic cancer	1.99e-06	2.76e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTEN—hematologic cancer	1.98e-06	2.76e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.96e-06	2.73e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.95e-06	2.72e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.95e-06	2.71e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—MTHFR—hematologic cancer	1.94e-06	2.7e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ALB—hematologic cancer	1.92e-06	2.67e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.9e-06	2.65e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—EP300—hematologic cancer	1.89e-06	2.63e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ALB—hematologic cancer	1.88e-06	2.61e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.87e-06	2.61e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CG—hematologic cancer	1.86e-06	2.59e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.84e-06	2.56e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.81e-06	2.52e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.8e-06	2.5e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NQO1—hematologic cancer	1.77e-06	2.46e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CD44—hematologic cancer	1.77e-06	2.46e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—AKT1—hematologic cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.74e-06	2.42e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.4e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AKT1—hematologic cancer	1.72e-06	2.39e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.7e-06	2.36e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.67e-06	2.33e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.67e-06	2.33e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.66e-06	2.31e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.66e-06	2.31e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.65e-06	2.29e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.28e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.63e-06	2.27e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ALB—hematologic cancer	1.63e-06	2.26e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.6e-06	2.22e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.56e-06	2.16e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.55e-06	2.16e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.15e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.52e-06	2.12e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CREBBP—hematologic cancer	1.51e-06	2.11e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.47e-06	2.05e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.47e-06	2.05e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTEN—hematologic cancer	1.47e-06	2.04e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ALB—hematologic cancer	1.45e-06	2.02e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.44e-06	2e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.43e-06	2e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTEN—hematologic cancer	1.43e-06	1.99e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CB—hematologic cancer	1.43e-06	1.99e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ALB—hematologic cancer	1.42e-06	1.97e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.41e-06	1.97e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.94e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—EP300—hematologic cancer	1.4e-06	1.94e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.39e-06	1.94e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.39e-06	1.93e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—EP300—hematologic cancer	1.37e-06	1.9e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.34e-06	1.86e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALB—hematologic cancer	1.32e-06	1.84e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.28e-06	1.78e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.27e-06	1.76e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.25e-06	1.74e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTEN—hematologic cancer	1.24e-06	1.73e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTEN—hematologic cancer	1.23e-06	1.72e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.2e-06	1.66e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—EP300—hematologic cancer	1.18e-06	1.65e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—EP300—hematologic cancer	1.18e-06	1.64e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.17e-06	1.63e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AKT1—hematologic cancer	1.14e-06	1.59e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTEN—hematologic cancer	1.11e-06	1.54e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTEN—hematologic cancer	1.08e-06	1.5e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—EP300—hematologic cancer	1.06e-06	1.47e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.44e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—EP300—hematologic cancer	1.03e-06	1.43e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.01e-06	1.41e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTEN—hematologic cancer	1.01e-06	1.4e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.4e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—EP300—hematologic cancer	9.63e-07	1.34e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.32e-07	1.3e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.84e-07	1.23e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	8.75e-07	1.22e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALB—hematologic cancer	8.73e-07	1.21e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—hematologic cancer	8.7e-07	1.21e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AKT1—hematologic cancer	8.44e-07	1.17e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.35e-07	1.16e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AKT1—hematologic cancer	8.25e-07	1.15e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.81e-07	1.09e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.71e-07	1.07e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.62e-07	1.06e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AKT1—hematologic cancer	7.15e-07	9.95e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.12e-07	9.91e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AKT1—hematologic cancer	7.11e-07	9.89e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTEN—hematologic cancer	6.66e-07	9.26e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AKT1—hematologic cancer	6.38e-07	8.88e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—EP300—hematologic cancer	6.35e-07	8.83e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AKT1—hematologic cancer	6.23e-07	8.66e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AKT1—hematologic cancer	5.82e-07	8.09e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.7e-07	6.53e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKT1—hematologic cancer	3.84e-07	5.34e-06	CbGpPWpGaD
